How a non-prescription medication brand grew 55% over 2 years

Products - Data Briefs - Number 470 - June 2023

Explaining the Prescription Drug Provisions in the Inflation Reduction Act

Navigating pharma loss of exclusivity

Baby Foods With Toxic Metals Stay on US Market While FDA Dithers

JRFM, Free Full-Text

The top 15 generic drugmakers by 2016 revenue

Cheapest Humira Alternative to Be Sold by Mark Cuban's Cost Plus Drugs - Bloomberg

Prescription Drugs: Spending, Use, and Prices

Products - Data Briefs - Number 470 - June 2023

Why Are Companies Launching Biosimilars With 2 Prices? Julie Reed Explains